[The ABCs of transfusion for hematologists]

Area of Science:

• Transfusion Medicine
• Hematology
• Clinical Guidelines

Background:

• Transfusion of blood products, including red blood cells, platelets, and fresh frozen plasma, carries inherent risks.
• Potential adverse events range from acute reactions like transfusion-related acute lung injury to delayed complications such as transfusion-transmitted infections.
• Hematologists require up-to-date knowledge of these risks to ensure patient safety.

Purpose of the Study:

• To provide evidence-based guidelines for the appropriate use of red blood cell products, platelet transfusion concentrates, and fresh frozen plasma.
• To inform clinicians about transfusion-associated adverse events and their management.
• To establish clear indications and trigger values for blood product transfusions.

Main Methods:

• Compilation and synthesis of scientific evidence related to blood product transfusion.
• Development of clinical recommendations based on the evaluated evidence.
• Focus on specific blood products: red blood cells, platelets, and fresh frozen plasma.

Main Results:

• Publication of comprehensive guidelines by the Japan Society of Transfusion Medicine and Cell Therapy.
• Detailed information on various transfusion-associated adverse events (e.g., TRALI, TACO, GVHD, viral transmission).
• Establishment of specific trigger values and indications for transfusion.

Conclusions:

• Adherence to these guidelines is crucial for the safe and effective use of blood products.
• Familiarity with transfusion risks and appropriate transfusion triggers is essential for hematologists.
• The guidelines aim to optimize patient outcomes by minimizing transfusion-related complications.